Skip to content
Inicio
Login
Descubre más: busca en todos nuestros recursos
All Fields
Title
Author
Subject
Find
Advanced
🎤
Mosunetuzumab plus polatuzumab...
Text this
Text this:
Mosunetuzumab plus polatuzumab vedotin in relapsed/refractory MCL after BTK inhibitor therapy
Number:
Provider:
Select your carrier
Cricket
T Mobile
Verizon
Virgin Mobile